Zinc Alpha 2 Glycoprotein Rekombinanter Antikörper
Zinc Alpha 2 Glycoprotein Rekombinant Antikörper für WB, Indirect ELISA
Wirt / Isotyp
Kaninchen / IgG
Getestete Reaktivität
human
Anwendung
WB, Indirect ELISA
Konjugation
Unkonjugiert
CloneNo.
251605B9
Kat-Nr. : 86781-3-PBS
Synonyme
Geprüfte Anwendungen
Produktinformation
86781-3-PBS bindet in WB, Indirect ELISA Zinc Alpha 2 Glycoprotein und zeigt Reaktivität mit human
| Getestete Reaktivität | human |
| Wirt / Isotyp | Kaninchen / IgG |
| Klonalität | Rekombinant |
| Typ | Antikörper |
| Immunogen | Zinc Alpha 2 Glycoprotein fusion protein Eg6736 |
| Vollständiger Name | alpha-2-glycoprotein 1, zinc-binding |
| Berechnetes Molekulargewicht | 298 aa, 34 kDa |
| Beobachtetes Molekulargewicht | 41 kDa |
| GenBank-Zugangsnummer | BC033830 |
| Gene symbol | Zinc Alpha 2 Glycoprotein |
| Gene ID (NCBI) | 563 |
| Konjugation | Unkonjugiert |
| Form | Liquid |
| Reinigungsmethode | Protein-A-Reinigung |
| Lagerungspuffer | PBS only |
| Lagerungsbedingungen | Store at -80°C. 20ul Größen enthalten 0,1% BSA. |
Hintergrundinformationen
Zinc-alpha-2-glycoprotein (AZGP1) is a 41-kDa soluble protein normally found in body fluids, functions as a lipid mobilizing factor (PMID: 19188554). It is known to be expressed in the secretory epithelia of the liver, lung, breast, GI tract and sweat glands, sharing significant structural similarity with the class I major histocompatibility complex (MHC) antigens (PMID: 3422450). AZGP1 is involved in carcinogenesis and differentiation. Altered expression of AZGP1 has been reported in breast cancer, prostate cancer and lung adenocarcinoma, hepatocellular carcinoma, pancreatic carcinoma and oral tumors (PMID: 22625427).

